D. Boral Capital Stock Recommendations and Price Targets

This is a list of recent ratings by D. Boral Capital.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
12/6/2024
URGN
UroGen Pharma
Reiterated Rating$12.00$25.00 ➝ $25.00Buy ➝ BuyN/A
12/5/2024
CANF
Can-Fite BioPharma
Reiterated Rating$2.00$10.00 ➝ $10.00Buy ➝ BuyN/A
12/4/2024
TRVI
Trevi Therapeutics
Reiterated Rating$3.00$21.00 ➝ $21.00Buy ➝ BuyN/A
12/4/2024
COYA
Coya Therapeutics
Initiated Coverage$6.00 $15.00BuyN/A
12/3/2024
ENLV
Enlivex Therapeutics
Reiterated Rating$1.00$13.00 ➝ $13.00Buy ➝ BuyN/A
12/2/2024
MNOV
MediciNova
Initiated Coverage$2.00$9.00 ➝ $9.00Buy ➝ BuyN/A
11/27/2024
CLGN
CollPlant Biotechnologies
Reiterated Rating$4.00$14.00 ➝ $14.00Buy ➝ BuyN/A
11/27/2024
CRVO
CervoMed
Reiterated Rating$12.00$34.00 ➝ $34.00Buy ➝ BuyN/A
11/25/2024
IMNN
Imunon
Reiterated Rating$1.00$29.00 ➝ $29.00Buy ➝ BuyN/A
11/25/2024
CNTX
Context Therapeutics
Initiated Coverage$2.00 $9.00BuyN/A
11/25/2024
AVXL
Anavex Life Sciences
Reiterated Rating$8.00$46.00 ➝ $46.00Buy ➝ BuyN/A
11/22/2024
CTXR
Citius Pharmaceuticals
Reiterated Rating$4.00Buy ➝ HoldN/A
11/21/2024
IVVD
Invivyd
Reiterated Rating$1.00$9.00 ➝ $9.00Buy ➝ BuyN/A
11/21/2024
AREC
American Resources
Reiterated Rating$1.00$4.00 ➝ $4.00Buy ➝ BuyN/A
11/21/2024
HUMA
Humacyte
Reiterated Rating$5.00$25.00 ➝ $25.00Buy ➝ BuyN/A
11/21/2024
IBRX
ImmunityBio
Reiterated Rating$5.00$30.00 ➝ $30.00Buy ➝ BuyN/A
11/20/2024
LCTX
Lineage Cell Therapeutics
Lower Price Target$1.00$3.00 ➝ $2.00Buy ➝ BuyN/A
11/20/2024
PED
PEDEVCO
Lower Price Target$1.00$2.25 ➝ $1.50Buy ➝ BuyN/A
11/20/2024
FBLG
FibroBiologics
Reiterated Rating$2.00$16.00 ➝ $16.00Buy ➝ BuyN/A
11/19/2024
GOVX
GeoVax Labs
Reiterated Rating$3.00$18.00 ➝ $18.00Buy ➝ BuyN/A
11/19/2024
ANIX
Anixa Biosciences
Reiterated Rating$3.00$10.00 ➝ $10.00Buy ➝ BuyN/A
11/19/2024
BMEA
Biomea Fusion
Reiterated Rating$6.00$128.00 ➝ $128.00Buy ➝ BuyN/A